Colgate-Palmolive Company $CL Stock: Mather Group LLC. Grows Position

Mather Group LLC. lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 112.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 26,990 shares of the company’s stock after acquiring an additional 14,287 shares during the period. Mather Group LLC.’s holdings in Colgate-Palmolive were worth $2,303,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CL. TD Capital Management LLC increased its stake in Colgate-Palmolive by 61.4% in the fourth quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after purchasing an additional 124 shares during the last quarter. Virginia Estate & Retirement Planning Advisors Inc. lifted its position in shares of Colgate-Palmolive by 1,409.1% during the 3rd quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after buying an additional 310 shares during the last quarter. Parvin Asset Management LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $32,000. Park Place Capital Corp boosted its holdings in shares of Colgate-Palmolive by 55.5% in the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after buying an additional 127 shares in the last quarter. Finally, Gould Capital LLC grew its position in shares of Colgate-Palmolive by 38.7% in the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock valued at $35,000 after buying an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This represents a 30.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the sale, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 175,191 shares of company stock valued at $16,110,903 over the last quarter. 0.43% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Performance

CL stock traded up $1.35 on Friday, hitting $94.02. The company’s stock had a trading volume of 5,775,087 shares, compared to its average volume of 5,409,072. The stock has a market cap of $74.95 billion, a price-to-earnings ratio of 37.31, a price-to-earnings-growth ratio of 4.43 and a beta of 0.33. The firm has a 50 day moving average of $89.05 and a two-hundred day moving average of $89.02. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. The company had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period last year, the firm posted $0.92 EPS. Equities analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is 84.13%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research analyst reports. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating on the stock in a research note on Monday, August 3rd. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating for the company in a research note on Monday, October 5th. TD Cowen raised their price objective on Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, August 3rd. Jefferies Financial Group reaffirmed a “hold” rating and set a $89.00 price objective (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Finally, BNP Paribas Exane cut their target price on Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, September 28th. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $97.95.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.